U.S. Stocks 

Fundamental Analysis: 

U.S. stocks recovered losses and turned higher after a sharp decline on Thursday, 25th February 2022, as investors flocked to large U.S. technology stocks for safe haven. Plus, a drop in oil prices eased market concerns that Russia’s invasion of Ukraine could lead to an immediate worsening of the inflation situation.

The S&P 500 rose by 1.5% and the Nasdaq 100 gained 3.4%. The Dow Jones Industrial Average gained 0.3% after the conflict between Ukraine and Russia overshadowed global markets and left the index hovering on the edge of a pullback zone.

Technical Analysis: 

(Dow 30, 1-hour chart) 

Execution Insight: 

The Dow focuses on the support of the 32083-line today. If the Dow runs steadily above the 32083-line, it will pay attention to the suppression of the 33390 and 33811 positions. If the Dow breaks below the 32083-line, it will pay attention to the support of the 31661-line.

Hong Kong Stocks 

Fundamental Analysis: 

U.S. stocks staged a stunning reversal overnight, as Hong Kong stocks rebounded, with the Hang Seng Index (HSI) rising by 0.03%, the Hang Seng China Enterprises Index (HSCEI) rising by 0.54%, and the Hang Seng TECH Index (HSTECH) rising by 1.72%.

On the market, large technology stocks that have been falling for several days generally rebounded. Bilibili Inc. (9626.HK) rose more than 9%, NetEase, Inc. (9999.HK) rose 3.5%, Kuaishou Technology (1024.HK), Baidu, Inc. (9888.HK), Meituan (3690.HK), and Alibaba Group Holding Limited (9988.HK) are up by more than 2%.

Biotechnology stocks rose collectively, while other industries’ stocks including power, sporting goods, mobile games, tobacco, and agriculture generally rose. At the same time, Pharmaron Beijing Co., Ltd. (3759.HK) sees a better performance with a significant opening of nearly 7%.

On the other hand, gas stocks fell sharply in front, with ENN Energy Holdings Limited (2688.HK) down by 9%. Simultaneously, gold stocks partially retraced, aviation stocks, and insurance stocks fell significantly.

Pharmaceutical sector rose, with WuXi Biologics (Cayman) Inc. (2269.HK) rising more than 4% to lead the blue chips. Financial stocks softened, with HSBC Holdings plc (0005.HK) falling by 3.5%, and AIA Group Limited (1299.HK) falling by nearly 2%.

Technical Analysis: 

(HK50, 1-hour chart) 

Execution Insight: 

HK50 Index focuses on the 22785-line today. If HK50 can run stably above the 22785-line, then pay attention to the suppression strength of the two positions of 23194 and 23818. If the HK50 strength breaks below the 22785-line, then pay attention to the support strength of the 21450-line.

FTSE China A50 Index 

Technical Analysis: 

(FTSE China A50, 1-hour chart) 

Execution Insight: 

FTSE China A50 pays attention to the suppression strength of the 15184-line today. If the A50 runs stably below the 15184-line, it will pay attention to the support strength of the two positions of 14669 and 13983. If the A50 strength breaks through the 15184-line, it will open up further upward trend. At that time, pay attention to the 15666-line of suppression strength.

Risk Disclosure
Trading in financial instruments involves a high degree of risk due to fluctuations in the value and price of the underlying financial instruments. Due to the adverse and unpredictable market movements, large losses exceeding the investor’s initial investment could incur within a short period of time. The past performance of a financial instrument is not an indication of its future performance.

Please make sure you read and fully understand the trading risks of the respective financial instrument before engaging in any transaction with us. You should seek independent professional advice if you do not understand the risks disclosed by us herein.

Disclaimer  
While every effort has been made to ensure the accuracy of the information in this document, DOO Prime does not warrant or guarantee the accuracy, completeness or reliability of this information. DOO Prime does not accept responsibility for any losses or damages arising directly or indirectly, from the use of this document. The material contained in this document is provided solely for general information and educational purposes and is not and should not be construed as, an offer to buy or sell, or as a solicitation of an offer to buy or sell, securities, futures, options, bonds or any other relevant financial instruments or investments. Nothing in this document should be taken as making any recommendations or providing any investment or other advice with respect to the purchase, sale or other disposition of financial instruments, any related products or any other products, securities or investments. Trading involves risk and you are advised to exercise caution in relation to the report. Before making any investment decision, prospective investors should seek advice from their own financial advisers, take into account their individual financial needs and circumstances and carefully consider the risks associated with such investment decision.